Literature DB >> 4812771

Proceedings: Combination chemotherapy of multiple myeloma with alkeran, cytoxan, vincristine, prednisone, and BCNU.

B J Lee, G Sahakian, B D Clarkson, I H Krakoff.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4812771     DOI: 10.1002/1097-0142(197402)33:2<533::aid-cncr2820330231>3.0.co;2-z

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  8 in total

1.  New treatments in myeloma--is cure possible?

Authors:  J S Malpas
Journal:  Postgrad Med J       Date:  1987-06       Impact factor: 2.401

2.  Immunoglobulin D myeloma: report of a case with unusual neurological complications.

Authors:  V Caggiano; S L Nielsen; F J Glassy; D F Dozier
Journal:  West J Med       Date:  1981-02

3.  Progress in myeloma at last.

Authors: 
Journal:  Br Med J       Date:  1978-06-24

4.  Peptichemio induction therapy in myelomatosis.

Authors:  G Merlini; P G Gobbi; A Riccardi; G Riva; C Sardi; S Perugini
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

5.  [Analysis of prognostic factors in plasmacytoma].

Authors:  W Gassmann; T Haferlach; N Schmitz; W Kayser; H H Euler; J Drews; H Löffler
Journal:  Klin Wochenschr       Date:  1984-10-01

Review 6.  Multiple myeloma.

Authors:  Robert A Kyle; S Vincent Rajkumar
Journal:  Blood       Date:  2008-03-15       Impact factor: 22.113

7.  Combination therapy for myelomatosis.

Authors:  L Azam; I W Delamore
Journal:  Br Med J       Date:  1974-12-07

8.  Objective evaluation of the role of vincristine in induction and maintenance therapy for myelomatosis. Medical Research Council Working Party on Leukaemia in Adults.

Authors:  I C MacLennan; J Cusick
Journal:  Br J Cancer       Date:  1985-08       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.